Project

Pharmacometrics: Clinical and pharmaceutical analysis

Code
bof/baf/4y/2024/01/226
Duration
01 January 2024 → 31 December 2025
Funding
Regional and community funding: Special Research Fund
Research disciplines
  • Medical and health sciences
    • Pharmacokinetics
Keywords
Mass spectrometry PKPD modelling PBPK modeling Pharmacometrics bioanalysis
 
Project description

Pharmacometrics is the discipline that includes the analysis and interpretation of measured data from (pre-)clinical drug research based on mathematical models.  On the basis of these models, calculations and simulations can be carried out to support the development of new drugs or perform dose adjustments (in relation to age, specific co-morbidities, etc.) for existing drugs. Development of models assumes analytical data are available.  Drug concentrations obtained from clinical studies are also necessary for the validation of such models. The determination of these measured values is performed via bioanalytical techniques in which quantitative mass spectrometry plays an important role. Since each drug is different, a specific analytical protocol needs to be developed and validated each time. The research focus is on antibiotics, chemotherapeutics, and specific populations (seniors, neonates, intensive care patients, ...).